Track topics on Twitter Track topics that are important to you
Eckert & Ziegler Strahlen- und Medizintechnik AG / Key word(s): Dividend/Annual Results
Berlin, 26 March 2019. Eckert & Ziegler Strahlen- und Medizintechnik AG (ISIN DE0005659700), a specialist for isotope-based applications in medicine, science and industry achieved sales of approx. 168.7 million EUR in the fiscal year 2018. As the Supervisory Board stated at its balance sheet meeting, the net profit was 16.1 million EUR or 3.12 EUR per share. For the fiscal year 2019, a net profit of about EUR 18 million is expected.
At the General Shareholders' Meeting to be held on 29 May 2019, the Executive Board and the Supervisory Board will propose a dividend of 1.20 EUR per share entitled to a dividend (previous year: 0.80 EUR per share).
The complete figures for the FY 2018 will be published on 5 April 2019.
For enquiries please contact:
|Company:||Eckert & Ziegler Strahlen- und Medizintechnik AG|
|Phone:||49 30 941084-138|
|Fax:||49 30 941084-112|
|Listed:||Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart, Tradegate Exchange|
|End of Announcement||DGAP News Service|
Original Article: Eckert & Ziegler Increases DividendNEXT ARTICLE
The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...